Brazil Veterinary Vaccines Market Size, Share & Trends Analysis Report By Product (Inactivated, Live Attenuated, Recombinant), By Animal Type (Swine, Fish, Poultry, Ruminants), And Segment Forecasts, 2020 - 2027
Brazil Veterinary Vaccines Market Growth & Trends
The Brazil veterinary vaccines market size is expected to reach USD 707.8 million by 2027 registering a CAGR of 6.4%, according to a new report by Grand View Research, Inc. Factors, such as increasing livestock population and mandatory vaccination, are propelling the growth of this market.
Growing prevalence of zoonotic diseases is further boosting the demand for vaccines. Favorable environment and increasing livestock population are among few factors that attract foreign companies to invest in the Brazil market. According to OECD, Brazil received about USD 62.7 billion in Foreign Direct Investment (FDI) in 2018. Foreign animal health companies also entered into the market by acquiring top regional companies. The aforementioned factors are expected to propel the market growth over the forecast period.
The massive outbreak of COVID-19 in countries, such as China and U.S., is expected to boost the growth of the Brazil’s meat export market. For instance, the Brazilian livestock production is expected to increase by nearly 5% due to the COVID-19 pandemic. China already increased its import of meat in 2019 due to the outbreak of African swine fever, which reduced its hog population.
Brazil Veterinary Vaccines Market Report Highlights
The Brazil veterinary vaccines market size is expected to reach USD 707.8 million by 2027 registering a CAGR of 6.4%, according to a new report by Grand View Research, Inc. Factors, such as increasing livestock population and mandatory vaccination, are propelling the growth of this market.
Growing prevalence of zoonotic diseases is further boosting the demand for vaccines. Favorable environment and increasing livestock population are among few factors that attract foreign companies to invest in the Brazil market. According to OECD, Brazil received about USD 62.7 billion in Foreign Direct Investment (FDI) in 2018. Foreign animal health companies also entered into the market by acquiring top regional companies. The aforementioned factors are expected to propel the market growth over the forecast period.
The massive outbreak of COVID-19 in countries, such as China and U.S., is expected to boost the growth of the Brazil’s meat export market. For instance, the Brazilian livestock production is expected to increase by nearly 5% due to the COVID-19 pandemic. China already increased its import of meat in 2019 due to the outbreak of African swine fever, which reduced its hog population.
Brazil Veterinary Vaccines Market Report Highlights
- Live attenuated segment led the global market in 2019. The dominance can be attributed to increased usage of this vaccines in mass vaccination
- On basis of animal type, ruminants held the largest revenue share in 2019 owing to increasing livestock population in the country and new product launches
- In 2017, Ceva entered into the FMD vaccine market in Brazil by acquiring Hertape Saude Animale Ltda and Inova Biotecnologia Sa?de Animale Ltda. The company accounted for around 15% of the FMD vaccine market in Brazil in 2017
- Boehringer Ingelheim acquired Merial in 2017 to increase its market penetration in Brazil. In 2017, MSD Animal Health acquired Vall?e to boost its vaccine portfolio
CHAPTER 1 RESEARCH METHODOLOGY AND SCOPE
1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation And Validation
1.6 Model Details
1.6.1 Model 1: Commodity Flow Approach
1.6.2 Model 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Report Objectives
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.1.1 Brazil Veterinary Vaccines Market Outlook, 2016 - 2027 (USD Million)
2.2 Segment Outlook
2.3 Brazil Veterinary Vaccines Market Summary, 2019
CHAPTER 3 BRAZIL VETERINARY VACCINES MARKET VARIABLES, TRENDS, AND SCOPE
3.1 Penetration & Growth Prospect Mapping
3.2 Brazil Veterinary Vaccines Market dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Rise in livestock population
3.2.1.2 Increasing prevalence of zoonotic diseases
3.2.1.3 Regulatory mandates for vaccination
3.2.2 MARKET RESTRAINT ANALYSIS
3.2.2.1 Volatility in exchange rates
3.2.2.2 Short product exclusivity period
3.3 Veterinary Vaccines Market Analysis Tools: Porters
3.3.1 Bargaining Power Of Suppliers: Low
3.3.2 Bargaining Power Of Buyers: Low
3.3.3 Threat Of Substitutes: Low
3.3.4 Threat Of New Entrants: Moderate
3.3.5 Competitive Rivalry: High
3.4 PESTEL Analysis
3.4.1 Political Landscape
3.4.2 Social & Economic Landscape
3.4.3 Technological Landscape
CHAPTER 4 VETERINARY VACCINES MARKET: COMPETITIVE ANALYSIS
4.1 Vendor Landscape
4.2 Market Leaders
4.2.1 Zoetis
4.2.2 Boehringer Ingelheim
4.2.3 Ceva Sante Animale
4.3 Market Innovators
4.4 Market Entry Strategies
4.5 Major Deals and Acquisitions
4.5.1 Mergers & Acquisitions
4.5.2 Product Launch
4.5.3 Expansion
4.6 Market Influencer Analysis
4.7 Consumer Preference Matrix
4.8 Estimated Company Market Share Analysis
CHAPTER 5 BRAZIL VETERINARY VACCINES MARKET: PRODUCT ESTIMATES AND FORECASTS TO 2027
5.1 Brazil veterinary vaccines Market: Product Movement A nalysis
5.1.1 Attenuated Live Vaccines
5.1.1.1 Attenuated live vaccines market estimates and forecasts, 2016 - 2027 (USD Million)
5.1.2 DNA Vaccines
5.1.2.1 DNA vaccines market estimates and forecasts, 2016 - 2027 (USD Million)
5.1.3 Recombinant Vaccines
5.1.3.1 Recombinant vaccines market estimates and forecasts, 2016 - 2027 (USD Million)
5.1.4 Inactivated Vaccines
5.1.4.1 INACTIVATED vaccines market estimates and forecasts, 2016 - 2027 (USD Million)
5.1.5 Others Vaccines
5.1.5.1 Others vaccines market estimates and forecasts, 2016 - 2027 (USD Million)
CHAPTER 6 BRAZIL VETERINARY VACCINES MARKET: ANIMAL TYPE ESTIMATES AND FORECASTS TO 2027
6.1 Brazil Veterinary Vaccines Market: Animal Type Movement Analysis
6.1.1 Poultry
6.1.1.1 Poultry market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.2 Infectious bronchitis
6.1.1.2.1 Infectious bronchitis market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.3 Avian influenza
6.1.1.3.1 Avian influenza market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.4 Marek’s disease
6.1.1.4.1 Marek’s disease market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.5 Newcastle disease
6.1.1.5.1 Newcastle Disease market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.6 Salmonella
6.1.1.6.1 Salmonella market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.7 Avian Encephalomyelitis
6.1.1.7.1 Avian Encephalomyelitis market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.8 Fowl Cholera
6.1.1.8.1 Fowl Cholera market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.9 Egg Drop Syndrome 76 (EDS 76)
6.1.1.9.1 Egg Drop Syndrome 76 (EDS 76) market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.10 Infectious coryza
6.1.1.10.1 Infectious coryza market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.11 Combined Vaccines
6.1.1.11.1 Combined Vaccines market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.12 Others
6.1.1.12.1 Others market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.2 AQUA
6.1.2.1 AQUA market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.2.2 Streptococcosis
6.1.2.2.1 Streptococcosis market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.2.3 Vibrio
6.1.2.3.1 Vibrio market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.2.4 Aeromonas
6.1.2.4.1 Aeromonas market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.2.5 Others
6.1.2.5.1 Others market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.3 Ruminants
6.1.3.1 Ruminants market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.3.2 Foot & mouth disease (FMD)
6.1.3.2.1 Foot & Mouth Disease (FMD) market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.3.3 Lumpy skin
6.1.3.3.1 Lumpy skin market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.3.4 Rotavirus
6.1.3.4.1 Rotavirus market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.3.5 Corona virus
6.1.3.5.1 Corona Virus market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.3.6 E.coli
6.1.3.6.1 E.coli market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.3.7 Blue tongue
6.1.3.7.1 Blue tongue market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.3.8 Combined vaccines
6.1.3.8.1 Combined vaccines market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.3.9 Others
6.1.3.9.1 Others market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.4 SWINE
6.1.4.1 Swine market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.4.2 Swine Influenza
6.1.4.2.1 Swine Influenza market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.4.3 Swine Fever
6.1.4.3.1 Swine Fever market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.4.4 Parvovirus
6.1.4.4.1 Parvovirus market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.4.5 PRRS
6.1.4.5.1 PRRS market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.4.6 Foot & Mouth Disease
6.1.4.6.1 Foot & Mouth Disease market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.4.7 Others
6.1.4.7.1 Others market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5 Companion
6.1.5.1 Companion market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.2 Canine
6.1.5.2.1 Canine market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.2.2 Canine distemper
6.1.5.2.2.1 Canine distemper market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.2.3 Kennel cough
6.1.5.2.3.1 Kennel cough market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.2.4 Parvovirus
6.1.5.2.4.1 Parvovirus market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.2.5 Canine herpes
6.1.5.2.5.1 Canine herpes market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.2.6 Lyme disease
6.1.5.2.6.1 Lyme disease market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.3 Feline
6.1.5.3.1 Feline market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.3.2 Rhinotracheitis
6.1.5.3.2.1 Rhinotracheitis market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.3.3 Calicivirus
6.1.5.3.3.1 Calicivirus market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.3.4 Corona virus
6.1.5.3.4.1 Corona virus market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.3.5 Panleukopenia
6.1.5.3.5.1 Panleukopenia market estimates and forecasts, 2016 - 2027 (USD Million)
CHAPTER 7 COMPANY PROFILES
7.1 Merck & Co., Inc.
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Product Benchmarking
7.1.4 Strategic Initiatives
7.2 Zoetis
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Product Benchmarking
7.2.4 Strategic Initiatives
7.3 Boehringer Ingelheim International GmbH
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Product Benchmarking
7.3.4 Strategic Initiatives
7.4 Biog?nesis Bag? S.A.
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Product Benchmarking
7.4.4 Strategic Initiatives
7.5 Ceva Sant? Animale
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6 Phibro Animal Health Corporation
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Product Benchmarking
7.6.4 Strategic Initiatives
7.7 Ourofino Sa?de Animal
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Product Benchmarking
7.7.4 Strategic Initiatives
7.8 Dechra Pharmaceuticals
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Product Benchmarking
7.8.4 Strategic Initiatives
7.9 Elanco
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Product Benchmarking
7.9.4 Strategic Initiatives
1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation And Validation
1.6 Model Details
1.6.1 Model 1: Commodity Flow Approach
1.6.2 Model 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Report Objectives
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.1.1 Brazil Veterinary Vaccines Market Outlook, 2016 - 2027 (USD Million)
2.2 Segment Outlook
2.3 Brazil Veterinary Vaccines Market Summary, 2019
CHAPTER 3 BRAZIL VETERINARY VACCINES MARKET VARIABLES, TRENDS, AND SCOPE
3.1 Penetration & Growth Prospect Mapping
3.2 Brazil Veterinary Vaccines Market dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Rise in livestock population
3.2.1.2 Increasing prevalence of zoonotic diseases
3.2.1.3 Regulatory mandates for vaccination
3.2.2 MARKET RESTRAINT ANALYSIS
3.2.2.1 Volatility in exchange rates
3.2.2.2 Short product exclusivity period
3.3 Veterinary Vaccines Market Analysis Tools: Porters
3.3.1 Bargaining Power Of Suppliers: Low
3.3.2 Bargaining Power Of Buyers: Low
3.3.3 Threat Of Substitutes: Low
3.3.4 Threat Of New Entrants: Moderate
3.3.5 Competitive Rivalry: High
3.4 PESTEL Analysis
3.4.1 Political Landscape
3.4.2 Social & Economic Landscape
3.4.3 Technological Landscape
CHAPTER 4 VETERINARY VACCINES MARKET: COMPETITIVE ANALYSIS
4.1 Vendor Landscape
4.2 Market Leaders
4.2.1 Zoetis
4.2.2 Boehringer Ingelheim
4.2.3 Ceva Sante Animale
4.3 Market Innovators
4.4 Market Entry Strategies
4.5 Major Deals and Acquisitions
4.5.1 Mergers & Acquisitions
4.5.2 Product Launch
4.5.3 Expansion
4.6 Market Influencer Analysis
4.7 Consumer Preference Matrix
4.8 Estimated Company Market Share Analysis
CHAPTER 5 BRAZIL VETERINARY VACCINES MARKET: PRODUCT ESTIMATES AND FORECASTS TO 2027
5.1 Brazil veterinary vaccines Market: Product Movement A nalysis
5.1.1 Attenuated Live Vaccines
5.1.1.1 Attenuated live vaccines market estimates and forecasts, 2016 - 2027 (USD Million)
5.1.2 DNA Vaccines
5.1.2.1 DNA vaccines market estimates and forecasts, 2016 - 2027 (USD Million)
5.1.3 Recombinant Vaccines
5.1.3.1 Recombinant vaccines market estimates and forecasts, 2016 - 2027 (USD Million)
5.1.4 Inactivated Vaccines
5.1.4.1 INACTIVATED vaccines market estimates and forecasts, 2016 - 2027 (USD Million)
5.1.5 Others Vaccines
5.1.5.1 Others vaccines market estimates and forecasts, 2016 - 2027 (USD Million)
CHAPTER 6 BRAZIL VETERINARY VACCINES MARKET: ANIMAL TYPE ESTIMATES AND FORECASTS TO 2027
6.1 Brazil Veterinary Vaccines Market: Animal Type Movement Analysis
6.1.1 Poultry
6.1.1.1 Poultry market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.2 Infectious bronchitis
6.1.1.2.1 Infectious bronchitis market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.3 Avian influenza
6.1.1.3.1 Avian influenza market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.4 Marek’s disease
6.1.1.4.1 Marek’s disease market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.5 Newcastle disease
6.1.1.5.1 Newcastle Disease market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.6 Salmonella
6.1.1.6.1 Salmonella market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.7 Avian Encephalomyelitis
6.1.1.7.1 Avian Encephalomyelitis market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.8 Fowl Cholera
6.1.1.8.1 Fowl Cholera market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.9 Egg Drop Syndrome 76 (EDS 76)
6.1.1.9.1 Egg Drop Syndrome 76 (EDS 76) market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.10 Infectious coryza
6.1.1.10.1 Infectious coryza market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.11 Combined Vaccines
6.1.1.11.1 Combined Vaccines market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.12 Others
6.1.1.12.1 Others market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.2 AQUA
6.1.2.1 AQUA market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.2.2 Streptococcosis
6.1.2.2.1 Streptococcosis market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.2.3 Vibrio
6.1.2.3.1 Vibrio market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.2.4 Aeromonas
6.1.2.4.1 Aeromonas market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.2.5 Others
6.1.2.5.1 Others market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.3 Ruminants
6.1.3.1 Ruminants market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.3.2 Foot & mouth disease (FMD)
6.1.3.2.1 Foot & Mouth Disease (FMD) market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.3.3 Lumpy skin
6.1.3.3.1 Lumpy skin market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.3.4 Rotavirus
6.1.3.4.1 Rotavirus market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.3.5 Corona virus
6.1.3.5.1 Corona Virus market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.3.6 E.coli
6.1.3.6.1 E.coli market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.3.7 Blue tongue
6.1.3.7.1 Blue tongue market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.3.8 Combined vaccines
6.1.3.8.1 Combined vaccines market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.3.9 Others
6.1.3.9.1 Others market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.4 SWINE
6.1.4.1 Swine market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.4.2 Swine Influenza
6.1.4.2.1 Swine Influenza market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.4.3 Swine Fever
6.1.4.3.1 Swine Fever market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.4.4 Parvovirus
6.1.4.4.1 Parvovirus market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.4.5 PRRS
6.1.4.5.1 PRRS market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.4.6 Foot & Mouth Disease
6.1.4.6.1 Foot & Mouth Disease market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.4.7 Others
6.1.4.7.1 Others market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5 Companion
6.1.5.1 Companion market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.2 Canine
6.1.5.2.1 Canine market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.2.2 Canine distemper
6.1.5.2.2.1 Canine distemper market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.2.3 Kennel cough
6.1.5.2.3.1 Kennel cough market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.2.4 Parvovirus
6.1.5.2.4.1 Parvovirus market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.2.5 Canine herpes
6.1.5.2.5.1 Canine herpes market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.2.6 Lyme disease
6.1.5.2.6.1 Lyme disease market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.3 Feline
6.1.5.3.1 Feline market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.3.2 Rhinotracheitis
6.1.5.3.2.1 Rhinotracheitis market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.3.3 Calicivirus
6.1.5.3.3.1 Calicivirus market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.3.4 Corona virus
6.1.5.3.4.1 Corona virus market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.5.3.5 Panleukopenia
6.1.5.3.5.1 Panleukopenia market estimates and forecasts, 2016 - 2027 (USD Million)
CHAPTER 7 COMPANY PROFILES
7.1 Merck & Co., Inc.
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Product Benchmarking
7.1.4 Strategic Initiatives
7.2 Zoetis
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Product Benchmarking
7.2.4 Strategic Initiatives
7.3 Boehringer Ingelheim International GmbH
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Product Benchmarking
7.3.4 Strategic Initiatives
7.4 Biog?nesis Bag? S.A.
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Product Benchmarking
7.4.4 Strategic Initiatives
7.5 Ceva Sant? Animale
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6 Phibro Animal Health Corporation
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Product Benchmarking
7.6.4 Strategic Initiatives
7.7 Ourofino Sa?de Animal
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Product Benchmarking
7.7.4 Strategic Initiatives
7.8 Dechra Pharmaceuticals
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Product Benchmarking
7.8.4 Strategic Initiatives
7.9 Elanco
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Product Benchmarking
7.9.4 Strategic Initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List Of distributors
Table 3 List of combined vaccines available in Brazil
Table 4 Leading market players anticipated to witness highest growth
Table 5 Brazil veterinary vaccines market, by Product type, 2016 - 2027 (USD Million)
Table 6 Brazil veterinary vaccines market, by animal type, 2016 - 2027 (USD Million)
Table 7 Brazil poultry vaccines market, by disease type, 2016 - 2027 (USD Million)
Table 8 Brazil ruminants vaccines market, by disease type, 2016 - 2027 (USD Million)
Table 9 Brazil swine vaccines market, by disease type, 2016 - 2027 (USD Million)
Table 10 Brazil companion vaccines market, by disease type, 2016 - 2027 (USD Million)
Table 11 Brazil aqua vaccines market, by disease type, 2016 - 2027 (USD Million)
Table 1 List of secondary sources
Table 2 List Of distributors
Table 3 List of combined vaccines available in Brazil
Table 4 Leading market players anticipated to witness highest growth
Table 5 Brazil veterinary vaccines market, by Product type, 2016 - 2027 (USD Million)
Table 6 Brazil veterinary vaccines market, by animal type, 2016 - 2027 (USD Million)
Table 7 Brazil poultry vaccines market, by disease type, 2016 - 2027 (USD Million)
Table 8 Brazil ruminants vaccines market, by disease type, 2016 - 2027 (USD Million)
Table 9 Brazil swine vaccines market, by disease type, 2016 - 2027 (USD Million)
Table 10 Brazil companion vaccines market, by disease type, 2016 - 2027 (USD Million)
Table 11 Brazil aqua vaccines market, by disease type, 2016 - 2027 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing and forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation and validation
Fig. 8 Brazil veterinary vaccines market: Model details
Fig. 9 Brazil veterinary vaccines market: Model details
Fig. 10 Brazil veterinary vaccines market outlook, 2016-2027 (USD million)
Fig. 11 Brazil veterinary vaccines market snapshot
Fig. 12 Brazil Veterinary vaccines market driver impact
Fig. 13 Veterinary vaccines market restraint impact
Fig. 14 Market entry strategies (Foreign & domestic)
Fig. 15 Strategy mapping
Fig. 16 Factors influencing Brazil veterinary vaccines market (2019, %)
Fig. 17 Consumer buying behavior
Fig. 18 Estimated company market share analysis (2019, %)
Fig. 19 Brazil veterinary vaccines market product outlook: Key takeaways
Fig. 20 Brazil veterinary vaccines market: product movement analysis
Fig. 21 Attenuated live vaccines market, 2016 - 2027 (USD Million)
Fig. 22 DNA vaccines market, 2016 - 2027 (USD Million)
Fig. 23 Recombinant vaccines market, 2016 - 2027 (USD Million)
Fig. 24 Inactivated vaccines market, 2016 - 2027 (USD Million)
Fig. 25 Others vaccines market, 2016 - 2027 (USD Million)
Fig. 26 Brazil veterinary vaccines market animal type outlook: Key takeaways
Fig. 27 Brazil veterinary vaccines market: animal type movement analysis
Fig. 28 Poultry market, 2016 - 2027 (USD Million)
Fig. 29 Infectious bronchitis market, 2016 - 2027 (USD Million)
Fig. 30 Avian influenza market, 2016 - 2027 (USD Million)
Fig. 31 Marek’s disease market, 2016 - 2027 (USD Million)
Fig. 32 Newcastle disease market, 2016 - 2027 (USD Million)
Fig. 33 Salmonella market, 2016 - 2027 (USD Million)
Fig. 34 Avian encephalomyelitis market, 2016 - 2027 (USD Million)
Fig. 35 Fowl Cholera market, 2016 - 2027 (USD Million)
Fig. 36 Egg drop syndrome 76 (EDS 76) market, 2016 - 2027 (USD Million)
Fig. 37 infectious coryza market, 2016 - 2027 (USD Million)
Fig. 38 Combined vaccines market, 2016 - 2027 (USD Million)
Fig. 39 Others market, 2016 - 2027 (USD Million)
Fig. 40 Aqua market, 2016 - 2027 (USD Million)
Fig. 41 Streptococcosis market, 2016 - 2027 (USD Million)
Fig. 42 Vibrio market, 2016 - 2027 (USD Million)
Fig. 43 Aeromonas market, 2016 - 2027 (USD Million)
Fig. 44 Others market, 2016 - 2027 (USD Million)
Fig. 45 Ruminants market, 2016 - 2027 (USD Million)
Fig. 46 Foot & mouth disease (FMD) market, 2016 - 2027 (USD Million)
Fig. 47 Lumpy skin market, 2016 - 2027 (USD Million)
Fig. 48 Rotavirus market, 2016 - 2027 (USD Million)
Fig. 49 Corona virus drugs market, 2016 - 2027 (USD Million)
Fig. 50 E.coli market, 2016 - 2027 (USD Million)
Fig. 51 Blue tongue market, 2016 - 2027 (USD Million)
Fig. 52 Combined vaccines market, 2016 - 2027 (USD Million)
Fig. 53 Others market, 2016 - 2027 (USD Million)
Fig. 54 Swine market, 2016 - 2027 (USD Million)
Fig. 55 Swine influenza market, 2016 - 2027 (USD Million)
Fig. 56 Swine fever market, 2016 - 2027 (USD Million)
Fig. 57 Parvovirus market, 2016 - 2027 (USD Million)
Fig. 58 PRRS market, 2016 - 2027 (USD Million)
Fig. 59 Foot & Mouth Disease market, 2016 - 2027 (USD Million)
Fig. 60 Others market, 2016 - 2027 (USD Million)
Fig. 61 Companion market, 2016 - 2027 (USD Million)
Fig. 62 Canine market, 2016 - 2027 (USD Million)
Fig. 63 Canine distemper market, 2016 - 2027 (USD Million)
Fig. 64 Kennel cough market, 2016 - 2027 (USD Million)
Fig. 65 Parvovirus market, 2016 - 2027 (USD Million)
Fig. 66 Canine herpes market, 2016 - 2027 (USD Million)
Fig. 67 Lyme disease market, 2016 - 2027 (USD Million)
Fig. 68 Feline market, 2016 - 2027 (USD Million)
Fig. 69 Rhinotracheitis market, 2016 - 2027 (USD Million)
Fig. 70 Calicivirus market, 2016 - 2027 (USD Million)
Fig. 71 Corona virus market, 2016 - 2027 (USD Million)
Fig. 72 Panleukopenia market, 2016 - 2027 (USD Million)
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing and forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation and validation
Fig. 8 Brazil veterinary vaccines market: Model details
Fig. 9 Brazil veterinary vaccines market: Model details
Fig. 10 Brazil veterinary vaccines market outlook, 2016-2027 (USD million)
Fig. 11 Brazil veterinary vaccines market snapshot
Fig. 12 Brazil Veterinary vaccines market driver impact
Fig. 13 Veterinary vaccines market restraint impact
Fig. 14 Market entry strategies (Foreign & domestic)
Fig. 15 Strategy mapping
Fig. 16 Factors influencing Brazil veterinary vaccines market (2019, %)
Fig. 17 Consumer buying behavior
Fig. 18 Estimated company market share analysis (2019, %)
Fig. 19 Brazil veterinary vaccines market product outlook: Key takeaways
Fig. 20 Brazil veterinary vaccines market: product movement analysis
Fig. 21 Attenuated live vaccines market, 2016 - 2027 (USD Million)
Fig. 22 DNA vaccines market, 2016 - 2027 (USD Million)
Fig. 23 Recombinant vaccines market, 2016 - 2027 (USD Million)
Fig. 24 Inactivated vaccines market, 2016 - 2027 (USD Million)
Fig. 25 Others vaccines market, 2016 - 2027 (USD Million)
Fig. 26 Brazil veterinary vaccines market animal type outlook: Key takeaways
Fig. 27 Brazil veterinary vaccines market: animal type movement analysis
Fig. 28 Poultry market, 2016 - 2027 (USD Million)
Fig. 29 Infectious bronchitis market, 2016 - 2027 (USD Million)
Fig. 30 Avian influenza market, 2016 - 2027 (USD Million)
Fig. 31 Marek’s disease market, 2016 - 2027 (USD Million)
Fig. 32 Newcastle disease market, 2016 - 2027 (USD Million)
Fig. 33 Salmonella market, 2016 - 2027 (USD Million)
Fig. 34 Avian encephalomyelitis market, 2016 - 2027 (USD Million)
Fig. 35 Fowl Cholera market, 2016 - 2027 (USD Million)
Fig. 36 Egg drop syndrome 76 (EDS 76) market, 2016 - 2027 (USD Million)
Fig. 37 infectious coryza market, 2016 - 2027 (USD Million)
Fig. 38 Combined vaccines market, 2016 - 2027 (USD Million)
Fig. 39 Others market, 2016 - 2027 (USD Million)
Fig. 40 Aqua market, 2016 - 2027 (USD Million)
Fig. 41 Streptococcosis market, 2016 - 2027 (USD Million)
Fig. 42 Vibrio market, 2016 - 2027 (USD Million)
Fig. 43 Aeromonas market, 2016 - 2027 (USD Million)
Fig. 44 Others market, 2016 - 2027 (USD Million)
Fig. 45 Ruminants market, 2016 - 2027 (USD Million)
Fig. 46 Foot & mouth disease (FMD) market, 2016 - 2027 (USD Million)
Fig. 47 Lumpy skin market, 2016 - 2027 (USD Million)
Fig. 48 Rotavirus market, 2016 - 2027 (USD Million)
Fig. 49 Corona virus drugs market, 2016 - 2027 (USD Million)
Fig. 50 E.coli market, 2016 - 2027 (USD Million)
Fig. 51 Blue tongue market, 2016 - 2027 (USD Million)
Fig. 52 Combined vaccines market, 2016 - 2027 (USD Million)
Fig. 53 Others market, 2016 - 2027 (USD Million)
Fig. 54 Swine market, 2016 - 2027 (USD Million)
Fig. 55 Swine influenza market, 2016 - 2027 (USD Million)
Fig. 56 Swine fever market, 2016 - 2027 (USD Million)
Fig. 57 Parvovirus market, 2016 - 2027 (USD Million)
Fig. 58 PRRS market, 2016 - 2027 (USD Million)
Fig. 59 Foot & Mouth Disease market, 2016 - 2027 (USD Million)
Fig. 60 Others market, 2016 - 2027 (USD Million)
Fig. 61 Companion market, 2016 - 2027 (USD Million)
Fig. 62 Canine market, 2016 - 2027 (USD Million)
Fig. 63 Canine distemper market, 2016 - 2027 (USD Million)
Fig. 64 Kennel cough market, 2016 - 2027 (USD Million)
Fig. 65 Parvovirus market, 2016 - 2027 (USD Million)
Fig. 66 Canine herpes market, 2016 - 2027 (USD Million)
Fig. 67 Lyme disease market, 2016 - 2027 (USD Million)
Fig. 68 Feline market, 2016 - 2027 (USD Million)
Fig. 69 Rhinotracheitis market, 2016 - 2027 (USD Million)
Fig. 70 Calicivirus market, 2016 - 2027 (USD Million)
Fig. 71 Corona virus market, 2016 - 2027 (USD Million)
Fig. 72 Panleukopenia market, 2016 - 2027 (USD Million)
